Elaine S. Jaffe
- Pathology and Forensic Medicine top 0.01%
- Lymphoma Diagnosis and Treatment 499
- Genetics top 0.01%
- Chronic Lymphocytic Leukemia Research 204
- Oncology top 0.01%
- Viral-associated cancers and disorders 233
- Dermatology top 0.01%
- Cutaneous lymphoproliferative disorders research 98
- Immunology top 0.02%
- T-cell and Retrovirus Studies 69
- Immune Cell Function and Interaction 68
-
- CNS Lymphoma Diagnosis and Treatment 96
-
- Eosinophilic Disorders and Syndromes 41
- Co-authors
- Nancy L. HarrisMark RaffeldStefania PittalugaJeffrey CossmanElı́as CampoSteven H. SwerdlowStefano PileriHarald Stein
- Partner nations
- United StatesGermanySpain
In The Last Decade
Elaine S. Jaffe
706 papers receiving 60.8k citations
Hit Papers
Peers
Comparison fields: 5 of 172
- Pathology and Forensic Medicine 37.8k
- Genetics 15.0k
- Oncology 28.2k
- Dermatology 7.7k
- Immunology 15.2k
Countries citing papers authored by Elaine S. Jaffe
This map shows the geographic impact of Elaine S. Jaffe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elaine S. Jaffe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elaine S. Jaffe more than expected).
Fields of papers citing papers by Elaine S. Jaffe
This network shows the impact of papers produced by Elaine S. Jaffe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elaine S. Jaffe. The network helps show where Elaine S. Jaffe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elaine S. Jaffe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 6 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 5 | |
| 6 | 2020 | 10 | |
| 7 | 2019 | 0 | |
| 8 | 2018 | 3 | |
| 9 | 2014 | 134 | |
| 10 | The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applicationsbreakdown → | 2011 | 1360 |
| 11 | 2010 | 123 | |
| 12 | 2009 | 371 | |
| 13 | 2009 | 36 | |
| 14 | 2008 | 217 | |
| 15 | 2008 | 221 | |
| 16 | 2006 | 11 | |
| 17 | Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease. | 2004 | 21 |
| 18 | Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico. | 1998 | 71 |
| 19 | 1998 | 34 | |
| 20 | 1983 | 18 |
About Elaine S. Jaffe
Elaine S. Jaffe is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 720 papers that have together received 63.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (499 papers), Viral-associated cancers and disorders (233 papers), Chronic Lymphocytic Leukemia Research (204 papers), Cutaneous lymphoproliferative disorders research (98 papers), CNS Lymphoma Diagnosis and Treatment (96 papers), T-cell and Retrovirus Studies (69 papers), Immune Cell Function and Interaction (68 papers) and Eosinophilic Disorders and Syndromes (41 papers). The work is most often cited by research in Pathology and Forensic Medicine (37.8k citations), Genetics (15.0k citations) and Oncology (28.2k citations). Elaine S. Jaffe has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Nancy L. Harris, Mark Raffeld, Stefania Pittaluga, Jeffrey Cossman, Elı́as Campo, Steven H. Swerdlow, Stefano Pileri, Harald Stein, Yoshihide Tsujimoto and Carlo M. Croce. Their work appears in journals such as Nature, Science and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.